心血管医学中的谵妄
本文综述了心血管医学中谵妄的流行病学、机制、临床表现、诊断、预防和治疗。接受经导管主动脉瓣置换、外科主动脉瓣置换、冠状动脉旁路移植或经皮冠状动脉介入等手术的患者可能尤其易感。谵妄与住院时间延长、死亡率增加和长期认知下降相关,需要主动的多学科管理。
要点
- 谵妄在心血管手术患者中常见且未被充分认识,与不良预后相关。
- CAM和CAM-ICU是已建立但未充分利用的诊断工具。
- 非药物多组分预防策略证据强,药物预防仍有争议。
核心结论
- 谵妄是心血管医学中常见且未被充分认识的神经精神综合征,与住院时间延长、死亡率增加和长期认知下降相关。
- 系统风险评估和多模式预防策略应成为标准治疗,药物治疗应针对症状和情境。
研究设计与样本
- 本文为当前文献的最新技术综述,整合了介入心脏病学、心脏外科和精神科的多学科专家讨论。
主要发现
- 谵妄发生率因心血管手术类型而异,受患者特征、手术侵入性和诊断方法影响。
- 危险因素包括高龄、基线认知障碍、脑血管疾病、手术时间延长、围手术期并发症和全身性炎症。
关键数值与推荐
- CAM和CAM-ICU评分是已建立的谵妄诊断工具,但在临床中未充分利用。
- 非药物多组分预防策略(如早期活动、认知刺激和睡眠卫生)有强证据支持。
- 右美托咪定在重症监护环境中显示益处,喹硫平和利培酮等抗精神病药可谨慎使用。
临床怎么用
- 对心血管手术患者应进行系统性谵妄风险评估。
- 采用非药物多组分预防策略作为标准治疗。
- 药物治疗应限于特定病例,根据症状和情境选择。
局限性
- 需要进一步高质量研究以制定针对心血管人群的循证指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Delirium is a common yet underrecognized neuropsychiatric syndrome in cardiovascular medicine associated with prolonged hospitalization, increased mortality, and long-term cognitive decline. Patients undergoing interventional or surgical cardiovascular procedures-such as transcatheter aortic valve replacement, surgical aortic valve replacement, coronary artery bypass grafting, or percutaneous coronary interventions-may be particularly vulnerable to its development. Delirium incidence varies widely across cardiovascular procedures, influenced by patient characteristics, procedural invasiveness, and diagnostic methodology. Risk factors include advanced age, baseline cognitive impairment, cerebrovascular disease, extended operative times, perioperative complications, and systemic inflammation. Diagnostic tools such as the Confusion Assessment Method (CAM) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) score are established but underutilized in the diagnosis of delirium. While preventive strategies emphasizing non-pharmacological, multicomponent approaches-such as early mobilization, cognitive stimulation, and sleep hygiene-are supported by strong evidence, preventive use of pharmacologic agents remains controversial. Pharmacologic treatment is reserved for select cases; dexmedetomidine shows benefits in intensive care unit settings, while antipsychotics like quetiapine and risperidone may be used cautiously. Overall, delirium poses a significant clinical challenge in cardiovascular medicine and requires a proactive, interdisciplinary approach. Systematic risk assessment and multimodal preventive strategies should be the standard of care, while pharmacologic treatment should be symptom- and context-specific. Further high-quality studies are needed to inform evidence-based guidelines tailored to cardiovascular populations. The present state-of-the-art review summarizes the current literature on the epidemiology, mechanisms, clinical manifestations, diagnosis, prevention, and treatment of delirium in cardiovascular medicine. By integrating findings and interdisciplinary expert discussions from interventional cardiology, cardiac surgery, and psychiatry, it aims to define the unique vulnerability of this patient population, highlight critical knowledge gaps, and lay the foundation for developing targeted, evidence-based management strategies.
引用
- Cekaj E, Vogel DHV, Spieth PM, et al. Delirium in cardiovascular medicine. Eur Heart J. 2026. PMID: 41711546. doi:10.1093/eurheartj/ehag088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。